Glucagon-like peptide-1 (GLP-1) as a new therapeutic approach for type-2 diabetes.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Glucagon-like peptide-1 (GLP-1) as a new therapeutic approach for type-2 diabetes. / Nauck, M.A.; Holst, Jens Juul; Willms, B.; Schmiegel, W.

I: Exp. Clin. Endocrinol. Diabetes, Nr. 105, 1997, s. 187-195.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Nauck, MA, Holst, JJ, Willms, B & Schmiegel, W 1997, 'Glucagon-like peptide-1 (GLP-1) as a new therapeutic approach for type-2 diabetes.', Exp. Clin. Endocrinol. Diabetes, nr. 105, s. 187-195.

APA

Nauck, M. A., Holst, J. J., Willms, B., & Schmiegel, W. (1997). Glucagon-like peptide-1 (GLP-1) as a new therapeutic approach for type-2 diabetes. Exp. Clin. Endocrinol. Diabetes, (105), 187-195.

Vancouver

Nauck MA, Holst JJ, Willms B, Schmiegel W. Glucagon-like peptide-1 (GLP-1) as a new therapeutic approach for type-2 diabetes. Exp. Clin. Endocrinol. Diabetes. 1997;(105):187-195.

Author

Nauck, M.A. ; Holst, Jens Juul ; Willms, B. ; Schmiegel, W. / Glucagon-like peptide-1 (GLP-1) as a new therapeutic approach for type-2 diabetes. I: Exp. Clin. Endocrinol. Diabetes. 1997 ; Nr. 105. s. 187-195.

Bibtex

@article{57cd7f7074cb11dbbee902004c4f4f50,
title = "Glucagon-like peptide-1 (GLP-1) as a new therapeutic approach for type-2 diabetes.",
author = "M.A. Nauck and Holst, {Jens Juul} and B. Willms and W. Schmiegel",
year = "1997",
language = "English",
pages = "187--195",
journal = "Exp. Clin. Endocrinol. Diabetes",
number = "105",

}

RIS

TY - JOUR

T1 - Glucagon-like peptide-1 (GLP-1) as a new therapeutic approach for type-2 diabetes.

AU - Nauck, M.A.

AU - Holst, Jens Juul

AU - Willms, B.

AU - Schmiegel, W.

PY - 1997

Y1 - 1997

M3 - Journal article

SP - 187

EP - 195

JO - Exp. Clin. Endocrinol. Diabetes

JF - Exp. Clin. Endocrinol. Diabetes

IS - 105

ER -

ID: 230057